secwatch.observer — SEC 8-K summary
======================================

Issuer:     VITASPRING BIOMEDICAL CO. LTD. (VSBC)
CIK:        0001697884
Form:       8-K
Filed at:   2026-09-10T17:22:10+00:00
Accession:  0001640334-26-001485
Event type: leadership
Sentiment:  neutral
Materiality: 0.60
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

VitaSpring Biomedical names Jing-Zhou Chen CEO/CFO, Shao-Hsiang Shih Chairman; Lai resigns
--------------------------------------------------------------------------------

- Ssu-Chuan Lai resigned as Chairperson, CEO, President, CFO, Secretary, and director effective 11:58 p.m. PT Sept 7, 2026; no disagreement cited.
- Jing-Zhou Chen, 40, appointed CEO, President, CFO, and Secretary effective 11:57 p.m. PT Sept 7, 2026; no employment agreement or compensation.
- Shao-Hsiang Shih, 54, elected director and appointed Chairman of the Board effective same time; no compensation.
- Both new appointees have no family relationships or material interests; indemnification agreements authorized but not yet executed.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1697884/000164033426001485/0001640334-26-001485-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1697884/000164033426001485/vsbc_8k.htm
  HTML page:      https://secwatch.observer/filing/0001640334-26-001485

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer